000724303 000__ 05721cam\a2200553Ii\4500 000724303 001__ 724303 000724303 005__ 20230306140527.0 000724303 006__ m\\\\\o\\d\\\\\\\\ 000724303 007__ cr\cn\nnnunnun 000724303 008__ 141114t20152015sz\a\\\\ob\\\\000\0\eng\d 000724303 019__ $$a900000484$$a908083418 000724303 020__ $$a9783319091624$$qelectronic book 000724303 020__ $$a331909162X$$qelectronic book 000724303 020__ $$z9783319091617 000724303 0247_ $$a10.1007/978-3-319-09162-4$$2doi 000724303 035__ $$aSP(OCoLC)ocn895254764 000724303 035__ $$aSP(OCoLC)895254764$$z(OCoLC)900000484$$z(OCoLC)908083418 000724303 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dE7B$$dYDXCP$$dCOO$$dOHI$$dOCLCF$$dIDEBK$$dEBLCP 000724303 049__ $$aISEA 000724303 050_4 $$aRC669 000724303 050_4 $$aRC903 000724303 08204 $$a616.6/1$$a616.1$$223 000724303 24500 $$aCardio-renal clinical challenges$$h[electronic resource] /$$cDavid Goldsmith, Adrian Covic, Jonas Spaak, editors. 000724303 264_1 $$aCham :$$bSpringer,$$c[2015] 000724303 264_4 $$c©2015 000724303 300__ $$a1 online resource :$$billustrations. 000724303 336__ $$atext$$btxt$$2rdacontent 000724303 337__ $$acomputer$$bc$$2rdamedia 000724303 338__ $$aonline resource$$bcr$$2rdacarrier 000724303 504__ $$aIncludes bibliographical references. 000724303 5050_ $$aForeword; Preface; Contents; Contributors; Part I: Cardiovascular Disease (CVD) in Chronic Kidney Disease (CKD): Same or Different?; 1: Epicardial Coronary Heart Disease in CKD: Diagnosis and Management; Chronic Kidney Disease (CKD) and Coronary Heart Disease: General Considerations; Clinical Evaluation of Coronary Heart Disease in CKD; Coronary Angiography; Contrast-Induced Acute Kidney Injury (CI-AKI); Risk of Bleeding; Anemia; Technique; Type of Stent; Other Peri-procedural Complications; Surgical Intervention; Medical Treatment; Aspirin; Clopidogrel; Prasugrel; Ticagrelor 000724303 5058_ $$aUnfractionated Heparin and Low Molecular Weight Heparin Glycoprotein IIb/IIIa Inhibitors; Bivalirudin; Beta-Blockers; Statins; Renin-Angiotensin-Aldosterone System Blockers; Nitrates; Control of Other Risk Factors; Special Considerations for Evaluating Patients Prior to Renal Transplantation; Summary and Conclusions; References; 2: Small Vessel Disease in CKD, Diabetes, Obesity and Hypertension; What Has Occurred in This gentleman's Kidneys over the Antecedent Years, and How Could This Have Been Prevented? 000724303 5058_ $$aSmall Artery Function and Dysfunction: Remodelling, Myogenic Tone and the EndotheliumEndothelial Dependent Mechanisms; Glomerular Endothelial Changes in Diabetes; Retinal Microvasculature and Cardiovascular Risk; Inflammation and Perivascular Adipose Tissue; "What Importance Does This Have for Our Patient in Clinic? And What Further Advice Can We Offer?"; References; 3: Sudden Cardiac Death and Arrhythmia in CKD; Introduction; Risk Factors and Mechanisms; Coronary Artery Disease; Arteriosclerosis and Arterial Calcification; Microvessel Disease; Cardiomyopathy and Cardiac Fibrosis 000724303 5058_ $$aSympathetic Overactivity Inflammation; Abnormalities in Mineral Metabolism; Electrolyte Shifts and Hypervolemia; QT Prolongation; Evidence for Best Management; Beta-Adrenergic Blockers; Renin-Angiotensin System (RAS) Blockade; Dialysis Dose and Avoiding low Potassium Dialysate; Management of Mineral Abnormalities; Implantable Cardiac Defibrillator; Provision of Healthcare; Conclusion; References; 4: Anticoagulation in CKD; Indications for Anticoagulation in Chronic Kidney Disease; Stroke Risk in Patients with Chronic Kidney Disease; Determining the Risk of Stroke 000724303 5058_ $$aWarfarin in Patients with Chronic Kidney Disease Direct-Acting Oral Anticoagulants (DOACs) in Chronic Kidney Disease; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Low Molecular Weight Heparins in Chronic Kidney Disease; Anticoagulation for Patients with Atrial Fibrillation on Peritoneal Dialysis; Anticoagulation for Atrial Fibrillation in Renal Transplant Patients; Assessing Risk of Bleeding in Patients with Chronic Kidney Disease; Conclusions; References; 5: MRA Inhibition in CKD: More Than Salt and Water; Introduction; Aldosterone 000724303 506__ $$aAccess limited to authorized users. 000724303 520__ $$aThis book provides a comprehensive overview of the clinical challenges faced during the treatment of patients with cardiorenal syndrome (CRS). The bidirectional link that associates renal and cardiovascular diseases means that patients with CRS have an increased risk of hospital admission and mortality as a result of their coexistence yet, there are no agreed guidelines for their management. Cardio-Renal Clinical Challenges takes clinical presentations and clinical problems as its base, and then discusses the evidence for best management of common clinical problems and the reasons for the complex interplay between the cardiac and renal systems. In addition, the link between heart failure and chronic kidney disease (CKD) can impose a considerable epidemiological burden thus this text also aims to address the issue of organizing healthcare to maximize both the opportunities for prevention and best healthcare economic returns. This book will be of immediate value and practical interest to all consulting and trainee cardiologists and renal physicians. 000724303 588__ $$aDescription based on online resource; title from PDF title page (viewed November 20, 2014). 000724303 650_0 $$aCardiovascular system$$xDiseases. 000724303 650_0 $$aKidneys$$xDiseases. 000724303 650_0 $$aHeart$$xDiseases. 000724303 7001_ $$aGoldsmith, David,$$d1959-$$eeditor. 000724303 7001_ $$aCovic, Adrian,$$eeditor. 000724303 7001_ $$aSpaak, Jonas,$$eeditor. 000724303 77608 $$iPrint version:$$z9783319091617 000724303 852__ $$bebk 000724303 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-09162-4$$zOnline Access$$91397441.1 000724303 909CO $$ooai:library.usi.edu:724303$$pGLOBAL_SET 000724303 980__ $$aEBOOK 000724303 980__ $$aBIB 000724303 982__ $$aEbook 000724303 983__ $$aOnline 000724303 994__ $$a92$$bISE